Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-10-18
DOI
10.1093/rheumatology/kex391
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study
- (2017) Daniel Aletaha et al. LANCET
- Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis
- (2016) Faith Matcham et al. BMC MUSCULOSKELETAL DISORDERS
- Interleukin-6: an emerging regulator of pathological pain
- (2016) Ya-Qun Zhou et al. Journal of Neuroinflammation
- Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways
- (2016) John A. Sturgeon et al. Nature Reviews Rheumatology
- Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
- (2016) Pietro Enea Lazzerini et al. Drug Design Development and Therapy
- Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder
- (2015) Rita Haapakoski et al. BRAIN BEHAVIOR AND IMMUNITY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Interleukin-6 as a predictor of symptom resolution in psychological distress: a cohort study
- (2015) M. Virtanen et al. PSYCHOLOGICAL MEDICINE
- Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials
- (2015) Ana-Maria Orbai et al. Current Rheumatology Reports
- A Mechanism-Based Approach to the Management of Osteoarthritis Pain
- (2015) Ezra Cohen et al. Current Osteoporosis Reports
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress
- (2014) Georgia E. Hodes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nociceptive neurons detect cytokines in arthritis
- (2014) Hans-Georg Schaible ARTHRITIS RESEARCH & THERAPY
- Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
- (2013) Maxime Dougados et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab Inhibits Structural Joint Damage and Improves Physical Function in Patients with Rheumatoid Arthritis and Inadequate Responses to Methotrexate: LITHE Study 2-year Results
- (2013) R. M. FLEISCHMANN et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis
- (2013) F. Matcham et al. RHEUMATOLOGY
- Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities
- (2013) Jürgen Scheller et al. SEMINARS IN IMMUNOLOGY
- Fatigue and Factors Related to Fatigue in Rheumatoid Arthritis: A Systematic Review
- (2013) Stephanie Nikolaus et al. ARTHRITIS CARE & RESEARCH
- Role of interleukin-6 in stress, sleep, and fatigue
- (2012) Nicolas Rohleder et al. Annals of the New York Academy of Sciences
- Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction
- (2012) Marni N. Silverman et al. Annals of the New York Academy of Sciences
- Spinal interleukin-6 is an amplifier of arthritic pain in the rat
- (2012) Enrique Vazquez et al. ARTHRITIS AND RHEUMATISM
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress
- (2012) Milena Girotti et al. PSYCHONEUROENDOCRINOLOGY
- The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review
- (2012) Alan M. Rathbun et al. RHEUMATOLOGY
- Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis
- (2012) E. Choy RHEUMATOLOGY
- Effect and Treatment of Chronic Pain in Inflammatory Arthritis
- (2012) Yvonne C. Lee Current Rheumatology Reports
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- IL-6/IL-6 receptor system and its role in physiological and pathological conditions
- (2011) Masahiko Mihara et al. CLINICAL SCIENCE
- Sleep Disturbances and Interleukin 6 Receptor Inhibition in Rheumatoid Arthritis
- (2011) K. FRAGIADAKI et al. JOURNAL OF RHEUMATOLOGY
- Hypothalamic–pituitary–adrenal axis dysfunction in chronic fatigue syndrome
- (2011) Andrew S. Papadopoulos et al. Nature Reviews Endocrinology
- Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF
- (2011) Gillian A. Hawker et al. ARTHRITIS CARE & RESEARCH
- Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
- (2010) G. R. Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
- (2010) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis
- (2010) B. J. Radovits et al. ARTHRITIS CARE & RESEARCH
- Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis
- (2010) Michael K Boettger et al. ARTHRITIS RESEARCH & THERAPY
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
- (2009) G. Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Depression, inflammation, and pain in patients with rheumatoid arthritis
- (2009) Masayo Kojima et al. ARTHRITIS AND RHEUMATISM
- A Meta-Analysis of Cytokines in Major Depression
- (2009) Yekta Dowlati et al. BIOLOGICAL PSYCHIATRY
- A Key Role for gp130 Expressed on Peripheral Sensory Nerves in Pathological Pain
- (2009) M. Andratsch et al. JOURNAL OF NEUROSCIENCE
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Functional polymorphisms in the interleukin-6 and serotonin transporter genes and depression and fatigue induced by interferon-α and ribavirin treatment
- (2008) S J Bull et al. MOLECULAR PSYCHIATRY
- Comorbid depression in rheumatoid arthritis: Pathophysiology and clinical implications
- (2008) Travis O. Bruce Current Psychiatry Reports
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now